Medico Reach

AUGUST 1, 2022

The early-stage venture financing firm Canaan Partners focuses on game-changing innovations in information, digital technologies, and the medical sciences. Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences. Canaan Partners.

Biopharma 52

Biopharma Healthcare Healthcare Specialization 52

European Pharmaceutical Review

MAY 23, 2024

Last month, CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) was the first BCMA-targeted CAR-T cell therapy to be approved for second-line treatment of multiple myeloma by the US Food and Drug Administration (FDA). Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S. Medical Affairs.

Food and Drug Administration 110

Food and Drug Administration Food Medical Medicine 110

Medgadget

MARCH 2, 2023

The first human trial done in Israel proved very successful (2017-2018, finalized during COVID), and published in the Red Journal , the official journal of the American Society for Radiation Oncology), involving many patients whose cancer recurred after treatment or whose options were exhausted. which are currently recruiting patients.

Manufacturing 83

Manufacturing Leads Patients Medicine 83